|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Number of the document | 1689737 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04797809.3 |
| Date of filing the European patent application | 2004-11-10 | |
| (97) | Date of publication of the European application | 2006-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-16 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/EP2004/012772 |
| Date | 2004-11-10 |
| (87) | Number | WO 2005/049600 |
| Date | 2005-06-02 |
| (30) | Number | Date | Country code |
| 0326407 | 2003-11-12 | GB |
| (72) |
ALVARO, Giuseppe, GlaxoSmithKline, IT
DI FABIO, Romano, GlaxoSmithKline, IT
GIOVANNINI, Riccardo, GlaxoSmithKline, IT
PAIO, Alfredo, GlaxoSmithKline, IT
TRANQUILLINI, Maria Elvira, GlaxoSmithKline, IT
MATTIOLI, Lucia, GlaxoSmithKline, IT
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Beta-laktamai, skirti CNS sutrikimų gydymui |
| BETA-LACTAMS FOR THE TREATMENT OF CNS DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2011-10-20 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2012-11-10 |